Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

In an added benefit, more than one in eight people taking the highest dose of Retratrutide were completely free of arthritic ...

Weight loss drug Ozempic has caused quite a stir this year, with many linking it to drastic celebrity weight loss. While ...

Novo Nordisk’s blockbuster diabetes drug, Ozempic, was officially launched in India on December 12. Unlike in the US and ...

If you've been on social media lately, you've probably noticed that Ozempic, Wegovy, and other GLP-1 drugs have dominated the conversation around weight loss. These medications have helped many people ...

The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines ...

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...

Step aside, semaglutide—retatrutide is showing the most impressive weight loss results of any obesity drug to date.

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

A weight loss drug dubbed the "triple G" drug for its effectiveness in mimicking three hunger-regulating hormones showed promising results in new data released Thursday by its maker, Eli Lilly.